We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Potential Drug Target for Diabetic Retinopathy

News   Sep 20, 2019 | Original story from Elsevier

 
A Potential Drug Target for Diabetic Retinopathy

ffect of recombinant lysyl oxidase propeptide (rLOX-PP) on the development of acellular capillaries (ACs) and pericyte loss (PL) in rat retinas. A-D: Representative retinal trypsin digest images showing retinal vascular networks of a control rat (A), diabetic (DM) rat (B), rat intravitreally injected with rLOX-PP (C), and rat intravitreally injected with phosphate-buffered saline (PBS) (D). LOX-PP administration promoted the development of ACs (arrows) and PL (arrowheads) associated with diabetic retinopathy. Enlarged images correspond to boxed areas (Right panels of A, B, C, D). Scale bar = 100 μm. Credit: The American Journal of Pathology

 
 
 

RELATED ARTICLES

Reducing Heart Attack-induced Tissue Damage by 30%

News

Scientists have discovered that inhibiting the synthesis of a lipid in a mouse suffering a heart attack reduces the tissue damage by 30%.

READ MORE

Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

News

Preclinical study findings suggest that targeting a promising bitter taste receptor with structurally distinct drugs could help prevent reduced therapeutic effectiveness over time.

READ MORE

New Insights Could Change How Concussions Are Treated

News

New research questions the ongoing hypothesis that the blunt force behind a traumatic brain injury (TBI) causes nerve damage, or axonal injury. The findings could influence the treatment of and development of new drugs for TBI.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE